Oral Metformin for Treatment of ABCA4 Retinopathy
NCT04545736
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
56
Enrollment
NIH
Sponsor class
Conditions
ABCA4 Retinopathy
Stargardt Disease
Retinal Dystrophy
Retinal Degeneration
Interventions
DRUG:
Metformin hydrochloride
Sponsor
National Eye Institute (NEI)